← Leaderboards
John David Altman
Emory University
$15,306,298
Attributed
$15,306,298
Total exposure
40
Grants
26
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.9M · FY2005–20$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$15,306,298 · 40
By mechanism
N01$4,177,324 · 1
R01$2,534,265 · 2
P30$2,322,857 · 2
U19$2,232,670 · 2
P51$2,093,429 · 29
R56$867,384 · 1
Top collaborators
No co-investigators on record.
Most similar at Emory University
Same institution · by research overlap
- Carlos Del Rio$49,445,541
- Henry M Blumberg$34,304,291
- Emily Rose Legan$146,921
- Aron Lukacher$17,098,629
- Daniel Kalman$11,539,324
Others in their field
Top investigators on “T-Lymphocyte”
- Barton F Haynes · Duke University$296,833,570
- Lawrence Corey · Fred Hutchinson Cancer Center$270,341,865
- Dan H. Barouch · Fred Hutchinson Cancer Center$117,305,894
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$107,651,960
- Alessandro Sette · La Jolla Institute For Immunology$75,756,097
- Rama Rao Amara · Emory University$69,530,112
Research focus
T-LymphocyteImmune ResponseReagentGrantResourcesProductionAllelesResearch PersonnelImmunologyUnited States National Institutes Of HealthSourceFundingPrimatesAntigensAnimalsAcquired Immunodeficiency SyndromeMacaca MulattaResponseInfectionNonhuman PrimateFlow CytometryInnovationCellsEpitope Mapping
Grant awards (73)
Immunology Core$253,664
U19 · FY2020 · AI · contact PI
Immunology Core$310,849
U19 · FY2019 · AI · contact PI
Immunology Core$220,814
U19 · FY2018 · AI · contact PI
Immunology Core$217,382
U19 · FY2017 · AI · contact PI
Immunology Core$251,932
U19 · FY2016 · AI · contact PI
Immunology Core$378,389
U19 · FY2015 · AI · contact PI
Immunology Core$338,538
U19 · FY2014 · AI · contact PI
Immunology Core$324,107
P30 · FY2012 · AI · contact PI
Tetramer Facility for Biodefense Research$1,680,589
N01 · FY2011 · AI · contact PI
Tetramer Facility for Immune-mediated diseases research$1,218,087
N01 · FY2011 · AI · contact PI
Immunology Core$389,549
P30 · FY2011 · AI · contact PI
Tetramer Facility for AIDS Research$334,044
N01 · FY2011 · AI · contact PI
INFLUENZA PATHOGENESIS AND IMMUNOLOGY RESEARCH CENTER:T CELL RESPONSES$123,370
P51 · FY2011 · RR · contact PI
NIAID TETRAMER FACILITY$74,294
P51 · FY2011 · RR · contact PI
MECHANISMS OF HELP FOR CD8 T CELL RESPONSES$74,294
P51 · FY2011 · RR · contact PI
Enhancing the Immunogenicity and Utility of MVA-Based AIDS Vaccines$1
R21 · FY2011 · AI · contact PI
Immunology Core$427,693
P30 · FY2010 · AI · contact PI
Enhancing the Immunogenicity and Utility of MVA-Based AIDS Vaccines$264,000
R21 · FY2010 · AI · contact PI
THE ROLE OF LEUKOCYTE SEQUESTRATION IN THE CONTROL OF VIRALINFECTIONS$54,827
P51 · FY2010 · RR · contact PI
CONTROLLING HIV/SIV WITH DRUGS THAT MANIPULATE LYMPHOCYTE TRAFFICKING$54,827
P51 · FY2010 · RR · contact PI
NIAID TETRAMER FACILITY$54,827
P51 · FY2010 · RR · contact PI
Tetramer Facility for Immune-mediated diseases research$629,736
N01 · FY2009 · AI · contact PI
Immunology Core$440,373
P30 · FY2009 · AI · contact PI
The Role of Leukocyte Sequestration in the Control of Viral Infections$433,692
R56 · FY2009 · AI · contact PI
Tetramer Facility for AIDS Research$314,868
N01 · FY2009 · AI · contact PI
THE ROLE OF LEUKOCYTE SEQUESTRATION IN THE CONTROL OF VIRALINFECTIONS$56,690
P51 · FY2009 · RR · contact PI
NIAID TETRAMER FACILITY$56,690
P51 · FY2009 · RR · contact PI
CONTROLLING HIV/SIV WITH DRUGS THAT MANIPULATE LYMPHOCYTE TRAFFICKING$56,690
P51 · FY2009 · RR · contact PI
OPTIMIZE THE IMMUNOGENICITY OF MVA-BASED AIDS VACCINES$56,690
P51 · FY2009 · RR · contact PI
The Role of Leukocyte Sequestration in the Control of Viral Infections$433,692
R56 · FY2008 · AI · contact PI
Immunology Core$380,685
P30 · FY2008 · AI · contact PI
DEVELOPMENT OF NOVEL T CELL ASSAYS$261,102
U19 · FY2008 · AI · contact PI
NIAID TETRAMER FACILITY$67,958
P51 · FY2008 · RR · contact PI
OPTIMIZE THE IMMUNOGENICITY OF MVA-BASED AIDS VACCINES$67,958
P51 · FY2008 · RR · contact PI
Immunology Core$360,450
P30 · FY2007 · AI · contact PI
T CELL REPERTOIRES SPECIFIC FOR DEFINED VIRAL EIPTOPES$65,453
P51 · FY2007 · RR · contact PI
EVALUATION OF CELLULAR IMMUNITY INDUCED BY HIV VACCINES$65,453
P51 · FY2007 · RR · contact PI
NIAID TETRAMER FACILITY$65,453
P51 · FY2007 · RR · contact PI
T Cell Repertoires Specific for Defined Viral Epitopes$312,480
R01 · FY2006 · AI · contact PI
NIAID TETRAMER FACILITY$59,665
P51 · FY2006 · RR · contact PI
EVALUATION OF CELLULAR IMMUNITY INDUCED BY HIV VACCINES$59,665
P51 · FY2006 · RR · contact PI
T CELL REPERTOIRES SPECIFIC FOR DEFINED VIRAL EIPTOPES$59,665
P51 · FY2006 · RR · contact PI
T Cell Repertoires Specific for Defined Viral Epitopes$320,000
R01 · FY2005 · AI
IN VITRO STIMULATION OF HIV SPECIFICS CD8+ T CELLS VACCINES$54,536
P51 · FY2005 · RR
T CELL REPERTOIRES SPECIFIC FOR DEFINED VIRAL EIPTOPES$52,438
P51 · FY2005 · RR
NIAID TETRAMER FACILITY$52,438
P51 · FY2005 · RR
EVALUATION OF CELLULAR IMMUNITY INDUCED BY HIV VACCINES$52,438
P51 · FY2005 · RR
DIETARY RESTRICTION AND AGING IN RHESUS MACAQUES$32,021
P51 · FY2005 · RR
T Cell Repertoires Specific for Defined Viral Epitopes$320,000
R01 · FY2004 · AI
IN VITRO STIMULATION OF HIV SPECIFIC CD8+ T CELL VACCINE$53,772
P51 · FY2004 · RR
T CELL REPERTOIRES SPECIFIC FOR DEFINED VIRAL EIPTOPES$51,707
P51 · FY2004 · RR
NIAID TETRAMER FACILITY$51,707
P51 · FY2004 · RR
EVALUATION OF CELLULAR IMMUNITY INDUCED BY HIV VACCINES$51,707
P51 · FY2004 · RR
DIETARY RESTRICTION AND AGING IN RHESUS MACAQUES$35,765
P51 · FY2004 · RR
MACAQUES MHC AND MOTIF ANALYSES$25,853
P51 · FY2004 · RR
T Cell Repertoires Specific for Defined Viral Epitopes$320,000
R01 · FY2003 · AI
PROJECT 3: MACAQUES MHCC AND MOTIF ANALYSIS$87,166
P51 · FY2003 · RR
IN VITRO STIMULATION OF HIV SPECIFICS CD8+ T CELLS VACCINES$49,264
P51 · FY2003 · RR
EVALUATION OF CELLULAR IMMUNITY INDUCED BY HIV VACCINES$47,395
P51 · FY2003 · RR
HIV - SPECIFIC CD8+ T CELLS FREQUENCIES AND PHENOTYPES$47,395
P51 · FY2003 · RR
FUNCTIONAL ANALYSIS HIV-1 SPECIFIC CTL TARGET CONJUGATE$47,395
P51 · FY2003 · RR
NIAID TETRAMER FACILITY$47,395
P51 · FY2003 · RR
T CELL REPERTOIRES SPECIFIC FOR DEFINED VIRAL EIPTOPES$47,395
P51 · FY2003 · RR
DIETARY RESTRICTION AND AGING IN RHESUS MACAQUES$31,173
P51 · FY2003 · RR
T Cell Repertoires Specific for Defined Viral Epitopes$314,300
R01 · FY2002 · AI
MACAQUE MHC AND MOTIF ANALYSES$159,181
P01 · FY2002 · AI
T CELL REPERTOIRES SPECIFIC FOR DEFINED VIRAL EPITOPES$244,403
R01 · FY2001 · AI
HIV-SPECIFIC CD8+ T CELLS--FREQUENCIES AND PHENOTYPES$236,285
R01 · FY2001 · AI
MACAQUE MHC AND MOTIF ANALYSES$159,181
P01 · FY2001 · AI
MACAQUE MHC AND MOTIF ANALYSES$256,006
P01 · FY2000 · AI
EFFECTS OF ANTI-4-1BB ON SIV-SPECIFIC CELLULAR IMMUNITY$240,000
R21 · FY2000 · AI
T CELL REPERTOIRES SPECIFIC FOR DEFINED VIRAL EPITOPES$237,341
R01 · FY2000 · AI
HIV-SPECIFIC CD8+ T CELLS--FREQUENCIES AND PHENOTYPES$229,456
R01 · FY2000 · AI